http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11960593

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 172
issn 0007-0920
1532-1827
issueIdentifier 1
pageRange 167-172
publicationName British Journal of Cancer
startingPage 167
bibliographicCitation Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee SK, Ahn YC, Jeong H, Son Y, Baek J, Park K. ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. British Journal of Cancer. 2008 Jul 01;99(1):167–72. doi: 10.1038/sj.bjc.6604464.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e06df6a87457b29d66ecc70feb517b00
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13f42ef1e6b13b95b087b5df6753868c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5e5fb027abb764bc76dced36e1ca01d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21e802891e779e7a55af3ef0d71a0b37
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_737be809cd055e1201dd0fda08561d79
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60c8cad567e7fee617b123ecdcb5674f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc8cc0a27fc51aa4fe9adca124972369
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55a4f86463968a70c4d96cdae9273131
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_147064b8605ef937c1db05a24b116726
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47ff8775a8b022406bafddae44519865
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e602653a798b3205a5cff09aa9c6f053
date 2008-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/sj.bjc.6604464
https://pubmed.ncbi.nlm.nih.gov/18594541
https://pubmed.ncbi.nlm.nih.gov/PMC2453006
isPartOf https://portal.issn.org/resource/ISSN/0007-0920
https://portal.issn.org/resource/ISSN/1532-1827
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
discusses http://id.nlm.nih.gov/mesh/M0007421
http://id.nlm.nih.gov/mesh/M0194055
http://id.nlm.nih.gov/mesh/M0006678
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0004505
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6651
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_216b3f57d0f687434bc29fb5794589c0
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128423931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129281950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127676247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764

Total number of triples: 51.